Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...

The Irish Examiner’s enduring health and wellbeing section has never shied away from intimate or taboo topics, givingprivate ...

I mentioned earlier in this post that Novo Nordisk markets and sells Wegovy, the obesity drug, and from the same underlying molecule - semaglutide - also market and sells Ozempic, indicated to ...

On Monday, the company filed a lawsuit against an Indianapolis-based med spa alleging trademark infringement and false advertising of its blockbuster ... and Novo Nordisk’s Ozempic and Wegovy (both ...

Story continues below this ad Not necessarily. Weight loss medications work in specific ... or it could disrupt normal body functions in unpredictable ways. For example, appetite-suppressing medicines ...

Here are just some of the examples ... Ozempic (semaglutide), and Trulicity (dulaglutide) can also aid in weight loss while lowering the risk of cardiovascular disease. With that said, changing for ...

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Novo Nordisk filed for approval of an oral, 25-mg formulation of its weight loss blockbuster “earlier this year,” according ...